Alaa H. M. Abdelrahman

In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors

Mahmoud A. A. Ibrahim, Alaa H. M. Abdelrahman, Taha A. Hussien et al. · Computers in Biology and Medicine · 2020 · 132 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease

Mahmoud Kandeel, Alaa H. M. Abdelrahman, Kentaro Oh‐hashi et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 95 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Natural-like products as potential SARS-CoV-2 M^pro inhibitors: <i>in-silico</i> drug discovery

Mahmoud A. A. Ibrahim, Khlood A. A. Abdeljawaad, Alaa H. M. Abdelrahman et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 87 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study

Mahmoud A. A. Ibrahim, Eslam A. R. Mohamed, Alaa H. M. Abdelrahman et al. · Journal of Molecular Graphics and Modelling · 2021 · 65 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors

Mahmoud A. A. Ibrahim, Alaa H. M. Abdelrahman, Khaled S. Allemailem et al. · The Protein Journal · 2021 · 62 citations · Full text

Pharmacy, Bioinformatics, Pharmacology +17